Martin Haraldsson
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Functional profiling of ovarian cancer models reveals Bcl-xL/NOTCH targeting to overcome resistance.
Functional profiling of ovarian cancer models reveals Bcl-xL/NOTCH targeting to overcome resistance.
Journal: NPJ precision oncology
Published: March 26, 2026
Disrupting Notch signalling by a small molecule inhibiting dihydroorotate dehydrogenase activity.
Journal: Scientific reports
Published: October 23, 2025
Albacarcin V adds EPLIN as a novel and promising target for the treatment of female cancers and pediatric medulloblastoma.
Journal: Biochemical pharmacology
Published: October 09, 2025
Challenging the "Undruggable"─Targeting STAT3 but Identifying Potent TrkA-Targeted Inhibitors.
Journal: Journal of medicinal chemistry
Published: April 17, 2025
ABHD2 activity is not required for the non-genomic action of progesterone on human sperm.
Journal: Human reproduction (Oxford, England)
Published: January 25, 2025
Discovery of a novel inhibitor of macropinocytosis with antiviral activity.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 16, 2024
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.
Journal: Nature communications
Published: August 18, 2023
Photo-physical characterization of high triplet yield brominated fluoresceins by transient state (TRAST) spectroscopy.
Journal: Methods and applications in fluorescence
Published: May 12, 2023
Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity.
Journal: Biochemical pharmacology
Published: May 24, 2022
Glioblastoma cytotoxicity conferred through dual disruption of endolysosomal homeostasis by Vacquinol-1.
Journal: Neuro-oncology advances
Published: November 12, 2021
Last Updated: 09/26/2026